DOW JONES NEWSWIRES A Philadelphia jury ruled in favor of drug maker Wyeth (WYE) in a wrongful death suit related to diet drug Pondimin. The verdict brought the company one step closer to resolving the diet-drug claims. About 5.8 million people took Wyeth's drugs Redux or Pondimin before they were removed from the market in 1997. The drugs constituted the fenfluramine portion of the once popular fen-phen diet combination and were found to damage heart valves in some patients. Phentermine, the other part, wasn't sold by Wyeth and is still on the market. The suits have cost Wyeth more than $21 billion in legal fees, judgments and settlements. The Philadelphia case involved the death of Edna Faye...
[read full story]
Your Web Site
